407 related articles for article (PubMed ID: 33643026)
1. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis.
Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY
Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the relations between gut microbiota and pathogens and Parkinson's disease.
Zhou S; Li B; Deng Y; Yi J; Mao G; Wang R; Zeng W; Liu B; Wu D; Liu F
Adv Clin Exp Med; 2023 Jun; 32(6):613-621. PubMed ID: 36881358
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
[TBL] [Abstract][Full Text] [Related]
4. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
5. High levels of
Zuo S; Wang H; Zhao Q; Tang J; Wang M; Zhang Y; Sang M; Tian J; Wang P
Front Integr Neurosci; 2022; 16():1054627. PubMed ID: 36686268
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the Parkinson's disease gut microbiome suggests alterations linked to intestinal inflammation.
Romano S; Savva GM; Bedarf JR; Charles IG; Hildebrand F; Narbad A
NPJ Parkinsons Dis; 2021 Mar; 7(1):27. PubMed ID: 33692356
[TBL] [Abstract][Full Text] [Related]
8. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
Nishiwaki H; Hamaguchi T; Ito M; Ishida T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
mSystems; 2020 Dec; 5(6):. PubMed ID: 33293403
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
10. Serum short-chain fatty acids and its correlation with motor and non-motor symptoms in Parkinson's disease patients.
Wu G; Jiang Z; Pu Y; Chen S; Wang T; Wang Y; Xu X; Wang S; Jin M; Yao Y; Liu Y; Ke S; Liu S
BMC Neurol; 2022 Jan; 22(1):13. PubMed ID: 34996385
[TBL] [Abstract][Full Text] [Related]
11. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson's disease.
Li F; Wang P; Chen Z; Sui X; Xie X; Zhang J
Neurosci Lett; 2019 Aug; 707():134297. PubMed ID: 31200089
[TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Gut Dysbiosis in Parkinson's Disease.
Nishiwaki H; Ito M; Ishida T; Hamaguchi T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
Mov Disord; 2020 Sep; 35(9):1626-1635. PubMed ID: 32557853
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
[TBL] [Abstract][Full Text] [Related]
14. Brain-gut-microbiota axis in Parkinson's disease.
Mulak A; Bonaz B
World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
19. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
[TBL] [Abstract][Full Text] [Related]
20. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]